Events

Recall of Beckman Coulter Glucose-STAT

According to New Zealand Medicines and Medical Devices Safety Authority, this recall involved a device in New Zealand that was produced by Beckman Coulter Inc.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    20263
  • Event Initiated Date
    2016-06-13
  • Event Country
    New Zealand
  • Event Source
    NZMMDSA
  • Event Source URL
    https://medsafe.govt.nz/hot/Recalls/RecallSearch.asp
  • Notes / Alerts
    Data from New Zealand is current through July 2018. All of the data comes from the New Zealand Medicines and Medical Devices Safety Authority, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and New Zealand.
  • Extra notes in the data
    Recalling Organisation: Beckman Coulter NZ Ltd, Suite 2, Level 4, 30 St Benedicts Street, Newton, AUCKLAND
  • Reason
    Previously unknown drug interferences from sulfasalazine and sulfapyridine have been identified., alt and glucose-stat are ivd products designed for the quantitative determination of alanine aminotransferase (alt) or glucose on the beckman coulter au series of analysers., there is a possibility that drug interferences from administration of sulfasalazine to patients may generate false low (alt) results and false low glucose-stat results ., sulfapyridine may generate false high glucose-stat results.
  • Action
    Software to be upgraded

Device

Beckman Coulter Glucose-STAT

Manufacturer

Beckman Coulter Inc